Category: SME IPO

Q-Line Biotech

Q-Line Biotech IPO: Comprehensive Analysis, Dates & Financial Overview

Q-Line Biotech IPO: Comprehensive Guide, Dates, Financials & Complete Analysis

The healthcare and diagnostics sector is experiencing massive transformations, and catching the wave early through public markets can often present intriguing opportunities. The upcoming Q-Line Biotech IPO has been gaining notable attention among retail and institutional market participants alike. In this comprehensive post, we will dissect the company’s core operations, structural offering details, financial health, and strategic objectives to help you make an informed decision.

Overview: What Does Q-Line Biotech Do?

Established in the year 2010, Q-Line Biotech Ltd. has built a robust footprint in the healthcare diagnostic arena. The enterprise is primarily engaged in the research, manufacturing, marketing, and distribution of an extensive range of medical diagnostic equipment and consumables.

Core Manufacturing: Indigenous production of reagents, spanning Clinical Chemistry, Haematology, Immunodiagnostics, and Molecular Diagnostics.
Equipment Supply: Distribution and importing of in-vitro diagnostics (IVD) and pathology devices catering directly to hospitals, medical colleges, and diagnostic centers.
Capacity & Scale: As of the latest operational reports, the company boasts an impressive annual capacity of nearly 1.4 million testing kits (including Rapid/Elisa) and 1,200 Selectra machines.
Workforce: A dedicated team of 126 in-house employees supported by over 200 third-party workers, working in synergy with an active R&D division.

Q-Line Biotech IPO Important Dates & Schedule

Keeping track of public issue timelines is crucial for a smooth application process. Below is the mapped-out schedule for the Q-Line Biotech IPO, from the opening of the bidding window to its eventual listing on the stock exchange.

May 21, 2026 Issue Opens

May 25, 2026 Issue Closes

May 26, 2026 Basis of Allotment

May 27, 2026 Refunds & Demat Credit

May 29, 2026 Listing Date

Event	Tentative Date
IPO Open Date	Thursday, May 21, 2026
IPO Close Date	Monday, May 25, 2026
Finalization of Allotment	Tuesday, May 26, 2026
Initiation of Refunds	Wednesday, May 27, 2026
Credit of Shares to Demat	Wednesday, May 27, 2026
Listing on NSE SME	Friday, May 29, 2026

Structural Details & Pricing Breakdown

The company aims to raise capital via a completely fresh issue mechanism, meaning the funds will be directed entirely to the company rather than early investors cashing out.

Specification	Details
Issue Type	Book Built Issue
Total Issue Size	₹214.48 Crores (62.53 Lakh Shares)
Face Value	₹10 per equity share
Price Band	₹326 to ₹343 per share
Listing Exchange	NSE SME
Offer Type	100% Fresh Issue

Investor Allocation Details

A well-structured distribution across different categories of market participants ensures wider market participation and stability upon listing.

Qualified Institutional Buyers (QIB): 49.99% of the net issue.
Non-Institutional Investors (NII/HNI): 15.01% of the net issue.
Retail Individual Investors (RII): 35.00% of the net issue.
Market Maker Reservation: 5.01% (Approx. 3.13 lakh shares).

Lot Size & Minimum Investment Requirements

To participate in this public offering, applicants must bid in lots. The designated base lot size dictates the minimum entry barrier for a retail investor.

Note for Retail Investors: According to the provided offering data, the minimum required application for a retail investor starts at 2 lots (800 shares), which corresponds to a minimum capital layout of ₹2,74,400 at the upper price band.

Investor Category	Minimum Lots	Total Shares	Investment Amount (at Upper Price)
Retail (Minimum)	2 Lots	800	₹2,74,400
Retail (Maximum)	2 Lots	800	₹2,74,400
Small HNI (Minimum)	3 Lots	1,200	₹4,11,600
Small HNI (Maximum)	7 Lots	2,800	₹9,60,400
Big HNI (Minimum)	8 Lots	3,200	₹10,97,600

Financial Performance Overview

Analyzing historical financial metrics provides deep insight into a company’s operational trajectory. The figures below showcase a restated consolidated view of the company’s financial standing over the past few years.

Financial Metric (₹ in Crores)	Period Ended Dec 31, 2025	FY March 31, 2025	FY March 31, 2024	FY March 31, 2023
Total Assets	561.34	455.49	339.25	251.58
Total Revenue	236.50	322.58	206.45	184.81
Profit After Tax (PAT)	38.69	28.13	34.44	32.10
EBITDA	64.23	71.32	37.63	32.98
Net Worth	(-0.04)	189.95	161.81	127.37
Total Borrowing	243.85	164.95	96.91	73.65

Observation: While assets and total revenue have showcased an upward trajectory generally, there has been a notable increase in total borrowings in the recent period. It is always wise to compare revenue generation against expanding debt liabilities.

Key Performance Indicators (KPIs)

Financial ratios help in benchmarking the valuation and operational efficiency of the business before its public debut.

KPI Metric	Dec 31, 2025	Mar 31, 2025
Return on Equity (ROE)	16.88%	17.66%
Return on Capital Employed (ROCE)	13.32%	23.74%
Debt to Equity Ratio	1.06	0.87
PAT Margin	16.65%	8.97%
EBITDA Margin	27.64%	22.73%

Objectives of the Public Issue

Capital raised through this fresh issue will be injected directly into the company’s structural ecosystem. The management has outlined clear strategic goals for the utilization of the estimated ₹183.50 Crores in net proceeds.

Allocation Purpose	Estimated Amount (₹ in Crores)
Meeting Working Capital Requirements	93.50
Repayment of Certain Borrowings (Part/Full)	90.00
General Corporate Purposes	Subject to finalization
Total Estimated Utilization	183.50

Promoter Details & Shareholding Pattern

The core leadership driving Q-Line Biotech includes Saurabh Garg, Amita Garg, Ayush Garg, Ajay Kumar Mahanty, and Abhay Agrawal. Consistent founder involvement is often seen as a pillar of long-term strategic execution.

Pre-Issue Promoter Holding: 96.77%
Post-Issue Holding: Will be diluted following the allocation of 62.53 lakh fresh shares to the public.

SWOT Analysis of Q-Line Biotech

Evaluating the holistic business environment is crucial for understanding potential market positioning post-listing:

Strengths: The company commands established manufacturing capabilities with a strong emphasis on reverse engineering, R&D, and quality control. Its diversified in-vitro diagnostics (IVD) portfolio and a geographically widespread distribution network fortify long-standing customer relationships.
Weaknesses: Rising total borrowings (Debt/Equity over 1.0) could strain free cash flows if interest coverage fluctuates. Furthermore, reliance on a vast number of third-party workers introduces variable dependencies.
Opportunities: The post-pandemic surge in healthcare awareness presents significant tailwinds. The planned reduction of debt through IPO proceeds will likely improve future profit margins and balance sheet strength.
Threats: The medical diagnostic space is fiercely competitive and highly regulated. Any adverse shifts in health compliance laws or aggressive pricing from larger market players could pose challenges.

Registrar & Contact Information

For any direct grievances, allotment status queries, or corporate inquiries, investors can reach out to the official registrar and the company via the following details:

Registrar to the Issue: Purva Sharegistry (India) Pvt.Ltd.
Email: support@purvashare.com

Company Address: Q-Line Biotech Ltd., 298-281, Transport Nagar, Kanpur Road (Adjacent Metro Station), Lucknow, Uttar Pradesh – 226012.
Compliance Email: compliance@qlinebiotech.com

Lead Managers representing the issue are Hem Securities Ltd. and Share India Capital Services Pvt.Ltd.

Conclusion

The Q-Line Biotech IPO represents an avenue to participate in India’s expanding healthcare and diagnostics ecosystem. The company demonstrates a well-diversified product line and solid manufacturing capacities. The primary objective to drastically reduce debt obligations using the public funds could clear a path for healthier balance sheets and unhindered future growth. However, as is the case with all market-linked instruments, potential participants should rigorously align these operational metrics with their personal risk appetite before making financial commitments.

May 20, 2026

M R Maniveni Foods

M R Maniveni Foods IPO: Complete Guide, Details, Dates, and Analysis

M R Maniveni Foods IPO: Complete Guide, Details, Dates, and In-Depth Analysis

Welcome to Publiclisting.in! The SME public offering space is buzzing with activity, and the upcoming M R Maniveni Foods IPO has captured the attention of market participants. Operating in the essential food processing industry, the company is preparing to enter the public market to fuel its next phase of manufacturing expansion.

Whether you are considering adding this stock to your portfolio or simply tracking market trends, understanding the fundamentals of the business is crucial. In this comprehensive guide, we will break down the company’s business operations, critical offering dates, financial health, and evaluate the potential risks and rewards through a detailed SWOT analysis.

Business Overview: What Does M R Maniveni Foods Do?

Incorporated over a decade ago in June 2010, M R Maniveni Foods Ltd. operates in the highly crucial agricultural and food processing sector. The company specializes in the processing, packaging, and distribution of essential food commodities, specifically focusing on Urad Dal and Toor Dal.

With a core commitment to delivering quality, safe, and hygienically prepared food, the brand relies on modern processing machinery and robust supply chain practices. Their primary clientele currently sits within the B2B (Business-to-Business) segment, ensuring a consistent volume-based operational flow. Armed with a compact team of 18 employees (as of July 2025), their long-term vision is directed towards creating strong brand recognition across both domestic and international borders.

Primary Offering Specifications

Before committing capital, investors need clarity on the size, structure, and pricing of the offering. The company is raising entirely fresh capital through a book-built issue framework on the BSE SME platform.

Parameter	Offering Details
Issue Type	Bookbuilding IPO
Total Issue Size	₹27.04 Crores (52,00,000 equity shares)
Offer Structure	100% Fresh Issue (No Offer for Sale)
Price Band	₹51 to ₹52 per share
Face Value	₹10 per share
Listing Exchange	BSE SME
Market Maker Reservation	2,60,000 shares (₹1.00 Cr)

Critical Dates and Timeline

Timing is everything in the stock market. Below is the detailed sequence of events for this SME offering. Mark these dates on your calendar to ensure you don’t miss the bidding window or the allotment updates.

Issue Opens

May 22, 2026

Issue Closes

May 26, 2026

Basis of Allotment

May 27, 2026

Refunds/Credit

May 29, 2026

Listing Date

Jun 1, 2026

Investment Requirements and Lot Sizes

SME offerings operate differently than mainboard public issues, particularly regarding minimum investment thresholds. Retail and High Net-worth Individuals (HNIs) must apply in predefined lot sizes.

Investor Category	Minimum Lots	Total Shares	Investment Amount (at ₹52)
Retail Individual (Min/Max)	1 Lot	4,000 Shares	₹2,08,000
Small HNI (Min)	3 Lots	6,000 Shares	₹3,12,000
Small HNI (Max)	9 Lots	18,000 Shares	₹9,36,000
Big HNI (Min)	10 Lots	20,000 Shares	₹10,40,000

Note on Category Reservations: The offering has reserved a maximum of 50% for Qualified Institutional Buyers (QIBs), a minimum of 35% for Retail Investors, and a minimum of 15% for Non-Institutional Investors (NIIs).

Financial Health and Performance Metrics

A closer look at the financial books reveals a strong top-line growth trajectory over the past three fiscal years. Let’s analyze how the company has managed its assets, revenues, and profitability.

Financial Parameter (₹ in Crores)	FY 2025 (Mar 31)	FY 2024 (Mar 31)	FY 2023 (Mar 31)
Total Assets	40.44	28.57	24.80
Total Income (Revenue)	203.52	155.00	119.61
Profit After Tax (PAT)	3.88	2.20	1.52
EBITDA	7.82	5.05	3.72
Net Worth	18.33	12.35	10.15
Total Borrowings	20.46	15.00	9.93

Key Performance Indicators (As of FY25)Return on Equity (ROE): 25.27%
Return on Capital Employed (ROCE): 18.63%
Debt-to-Equity Ratio: 1.12
PAT Margin: 1.90%
Price to Book Value (P/B): 4.02

Purpose of Capital Raise (Objectives)

It is generally a positive indicator when a company utilizes public funds for core expansion rather than cashing out existing promoters. M R Maniveni Foods plans to deploy the net proceeds for the following structural objectives:

₹12.69 Crores: Capital expenditure for the construction of a new factory to scale operations.
₹14.74 Crores: Procurement and installation of modern plant and machinery.
Remaining Funds: Allocated towards general corporate purposes to support day-to-day operations and contingencies.

Management and Shareholding

The strategic direction of the company is spearheaded by its core promoters: K R Manikandan, M Chandra, and K Selvam. Prior to the public offering, the promoters hold an overwhelming 98.68% stake in the company. After the fresh issue of 5.2 million shares is deployed, this stake will be appropriately diluted, though the exact post-issue holding percentage will depend on the final allotment structure.

SWOT Analysis of M R Maniveni Foods

Evaluating the internal and external factors is crucial for understanding the risk-reward ratio of this investment.

Strengths

Over a decade of established presence in the pulses and food commodity industry.
Clear B2B client base ensuring steady operational flow.
Healthy top-line revenue growth, scaling from ₹119 Cr in FY23 to ₹203 Cr in FY25.

Weaknesses

Low Profit After Tax (PAT) margins standing at just 1.90%, which is typical for trading/processing but limits safety nets.
Increasing total borrowings, leading to a moderately high Debt-to-Equity ratio of 1.12.
Very small direct employee base (18 members) managing large volumes, which may cause operational bottlenecks.

Opportunities

The proposed ₹27 Cr capital injection is heavily focused on infrastructure (factory and machinery), which can drastically improve production efficiency and margins.
Growing demand for hygienically packaged food in both rural and urban domestic sectors.
Potential to shift focus towards B2C distribution for higher profit margins in the future.

Threats

The food processing and agricultural commodity market is highly fragmented and fiercely competitive.
Vulnerability to raw material price fluctuations caused by uncontrollable factors like weather, crop yield, and government policies.
Strict and changing regulatory compliances related to food safety standards.

Intermediaries and Contact Information

If you need to reach out regarding allotment status or company queries, here are the official details:

Lead Manager: Capital Square Advisors Private Limited
Official Registrar: Bigshare Services Private Limited
Company Address: S.No.220/3A-3B, Madhavaram-Redhills High Road (Near Vadaperumbakkam), Madhavaram, Chennai, Tamil Nadu – 600060

Final Thoughts

The M R Maniveni Foods public offering presents an interesting opportunity to invest in a company that is actively trying to transition from a mid-sized processing unit to a larger scale manufacturing setup. The revenue growth is undeniably impressive, but investors must weigh this against the razor-thin profit margins and the inherent risks of the agricultural commodity market. The decision to invest should align with your personal risk tolerance and portfolio strategy within the SME space.

Disclaimer: The information provided in this article is for educational and informational purposes only. It does not constitute financial advice. Always consult with a certified financial advisor before making any investment decisions.

May 16, 2026

Autofurnish

Upcoming Autofurnish SME IPO: Complete Analysis, Financials & Dates

A Comprehensive Guide to the Autofurnish SME IPO: Should You Invest?

The Indian automotive accessory market is witnessing substantial growth, driven by an increasing number of vehicle owners who prefer personalizing and protecting their investments. Capitalizing on this trend is Autofurnish Ltd., a prominent player in the automotive accessories domain. The company is now preparing to enter the public market with its upcoming SME Initial Public Offering (IPO).

If you are exploring new investment opportunities in the SME segment, this detailed analysis will provide you with all the vital information, from business fundamentals and financial health to critical timelines and valuation metrics, helping you make a well-informed decision.

Business Overview: What Does Autofurnish Do?

Incorporated in May 2015, Autofurnish Ltd. specializes in the manufacturing, designing, and trading of automotive accessories. They have built a strong market presence catering to both two-wheelers and four-wheelers. The company strategically operates across two primary business models:

B2B Segment: Focused on manufacturing and distributing utility products like car body covers and premium foot mats under their established brands, “Autofurnish” and “Mototrance”.
B2C Segment: Operated via their subsidiary, Golden Mace Private Limited, the company directly reaches end consumers through major e-commerce platforms like Amazon, Flipkart, Zepto, and their proprietary website.

Quality and safety are core pillars of their manufacturing process. Their production facilities boast an impressive lineup of certifications, including ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, IATF 16949:2016, and GMP compliance. Alongside car accessories, they manufacture durable motorcycle gear, riding accessories, polishing pads, and towel cloths.

Key Highlights of the Public Offering

The company is launching a Fixed Price Issue to raise approximately ₹15 Crores. The issue entirely consists of fresh equity shares, with no Offer for Sale (OFS) component, meaning all raised funds will be directed back into the company’s growth initiatives.

Particulars	Details
Issue Type	Fixed Price SME IPO
Total Issue Size	35,61,000 Shares (Aggregating ~₹15.00 Cr)
Fresh Issue Size	33,81,000 Shares (~₹14.00 Cr)
Market Maker Portion	1,80,000 Shares (~₹0.73 Cr)
Issue Price	₹41 per equity share
Face Value	₹10 per share
Listing Platform	BSE SME

Crucial Dates & Application Schedule

Timing is everything in the stock market. Below is the complete schedule for the offering. Make sure to mark these dates on your calendar if you plan to bid.

Issue Opens

May 21, 2026

Issue Closes

May 25, 2026

Basis of Allotment

May 26, 2026

Refunds/Credit

May 27, 2026

Listing Date

May 29, 2026

Event	Tentative Date	Day of the Week
Bid/Offer Opening	May 21, 2026	Thursday
Bid/Offer Closing	May 25, 2026	Monday
Finalization of Allotment	May 26, 2026	Tuesday
Initiation of Refunds & Demat Credit	May 27, 2026	Wednesday
Listing on BSE SME	May 29, 2026	Friday

Minimum Investment Breakdown & Lot Size

In SME IPOs, trading occurs in standardized lot sizes rather than single shares. For this specific offering, an application requires a base of multiple lots. Below is the investment structure required for different investor categories:

Investor Category	Minimum Lots	Total Shares	Investment Amount (₹)
Retail Individual Investors (Min)	2 Lots	6,000	₹2,46,000
Retail Individual Investors (Max)	2 Lots	6,000	₹2,46,000
High Net-Worth Individuals (HNI)	3 Lots	9,000	₹3,69,000

Note: The standard lot size is 3,000 shares, but the minimum application size mandates at least 2 lots for retail participants.

Financial Health & Growth Metrics

Evaluating a company’s financial track record is critical before investing. A steady increase in revenue and consistent profitability are generally positive indicators. Here is a look at the restated consolidated financials over the last few fiscal years (Values in ₹ Crore).

Financial Metric	FY 2023 (Mar 31)	FY 2024 (Mar 31)	FY 2025 (Mar 31)	Period End (Dec 31, 2025)
Total Assets	14.11	16.01	23.28	33.50
Total Revenue	10.60	15.92	33.88	28.32
EBITDA	0.85	2.82	5.11	4.79
Profit After Tax (PAT)	0.16	1.63	3.50	2.83
Net Worth	7.50	9.07	14.71	17.57

Financial Observation: The company has displayed aggressive growth, with revenue more than doubling from FY24 (₹15.92 Cr) to FY25 (₹33.88 Cr). Consequently, the Profit After Tax (PAT) has also seen a significant leap, reflecting improved operational efficiency.

Valuation & Performance Indicators

Understanding how the issue is priced relative to its earnings can help gauge whether the stock is fairly valued. Based on the latest available financial data, here are the Key Performance Indicators (KPIs):

Key Metric	Value (As of Mar 31, 2025)
Return on Equity (ROE)	23.50%
Return on Capital Employed (ROCE)	33.74%
Debt to Equity Ratio	0.36
PAT Margin	10.51%
Pre-IPO EPS	₹3.52
Post-IPO P/E Ratio (Approx)	14.7x

Fund Utilization Plan: Where is the Money Going?

The total capital raised via this fresh issue is estimated to be utilized strategically to fuel further expansion. The estimated breakdown of the fund allocation is as follows:

Working Capital Requirements: ₹9.50 Crores to ensure smooth day-to-day operations and inventory management.
General Corporate Purposes: ₹1.96 Crores allocated for broader company-level strategic initiatives.
Capital Expenditure (Machinery): ₹1.89 Crores to purchase new manufacturing equipment, boosting production capacity.
Issue Management Expenses: ₹1.45 Crores to cover the legal, regulatory, and marketing costs associated with the IPO.

Ownership Structure & Promoters

The driving force behind the company includes Mr. Puneet Arora and Mr. Ruppal Wadhwa. A high promoter holding typically indicates strong faith by the founders in their business model.

Holding Stage	Promoter Stake (%)
Pre-Issue Holding	93.10%
Post-Issue Holding	68.57%

Post-listing, the promoters will continue to retain a commanding majority stake of 68.57%, ensuring their interests remain aligned with long-term shareholder value.

SWOT Analysis of the Company

To provide a balanced perspective, here is a quick SWOT analysis of the company’s business positioning:

Strengths: A highly diversified product portfolio under one roof, extensive ISO and GMP certifications guaranteeing product quality, and a robust dual approach covering both B2B and B2C markets.
Weaknesses: High reliance on third-party e-commerce platforms (like Amazon and Flipkart) for retail sales, which subjects them to changing platform algorithms and commission structures.
Opportunities: The rapidly expanding domestic automotive sector and a booming EV market provide a massive runway for customized automotive accessories.
Threats: The auto accessories market is heavily fragmented with intense competition from unorganized local players and price volatility in raw materials like rubber and textiles.

Key Intermediaries & Contact Information

For investors requiring further assistance or those who need to address grievances post-allotment, the following registered entities are managing the issue:

Lead Manager: Novus Capital Advisors Pvt. Ltd.
Registrar to the Issue: Skyline Financial Services Pvt. Ltd.
Market Maker: NDA Securities Ltd.

Company Contact Details

Autofurnish Ltd.
K-55, Udyog Nagar, Peeragarhi,
Nangloi West Delhi, New Delhi, 110041
Email: corporate@autofurnish.com

Final Thoughts

The SME public offering by Autofurnish brings forward an interesting proposition within the automotive ancillary space. Backed by solid revenue growth over the last three years and a healthy Return on Capital Employed (ROCE) of over 33%, the business exhibits strong fundamental momentum. Furthermore, utilizing a significant portion of the IPO proceeds for capacity expansion and working capital paints a forward-looking picture.

As is standard with all SME listings, the larger lot size involves higher capital deployment and potentially different liquidity dynamics compared to mainboard listings. Investors should weigh the company’s growth trajectory against the broader market conditions and their individual risk appetite before participating.

May 16, 2026

Harikanta Overseas

Harikanta Overseas IPO Analysis, Dates, Price Band & Financials | Publiclisting.in

Harikanta Overseas IPO: Complete Analysis, Financials, and Investment Guide

Welcome to Publiclisting.in! The Indian SME market is buzzing with fresh opportunities, and the latest entrant seeking to capture investor attention is Harikanta Overseas Ltd. With the textile industry acting as a backbone for India’s growing export economy, this manufacturing company is stepping into the public market to fund its next phase of growth.

In this comprehensive guide, we will break down everything you need to know about the Harikanta Overseas IPO. From crucial dates and lot sizes to an in-depth look at their financial health and future objectives, our goal is to provide you with clear, unbiased, and highly informative data so you can navigate this investment opportunity with confidence.

Business Overview: What Does Harikanta Overseas Do?

Incorporated in 2018, Harikanta Overseas Ltd. operates in the highly dynamic sector of synthetic textile fabric manufacturing. Over the years, the company has built a robust product portfolio catering to both domestic and international fashion demands.

Core Products: The company specializes in manufacturing Ikat fabrics, polyester garment fabrics, saree materials, dhupion fabrics, poly linen, and natural fiber fabrics.
Target Audience: A major portion of their production is dedicated to women’s ethnic wear, including sarees, kurtas, and dress materials. They also produce fabrics for men’s traditional wear.
Infrastructure: Their state-of-the-art manufacturing unit is strategically located in Surat, Gujarat—the textile hub of India—spreading across nearly 954 sq. meters.
Market Reach: Domestically, they have a strong footprint in Delhi, Karnataka, Maharashtra, UP, Punjab, and Rajasthan. Internationally, they export to markets like Singapore, Bahrain, and Thailand.

Harikanta Overseas IPO Specifications

Before committing your capital, it is essential to understand the structure of the IPO. This issue is an entirely fresh issue, meaning all the funds raised will go directly to the company rather than existing promoters selling their stakes.

IPO Attribute	Details
Issue Type	Book Built Issue (SME)
Total Issue Size	₹25.63 Crores (26.70 Lakh Shares)
Price Band	₹91 to ₹96 per equity share
Face Value	₹10 per share
Listing Platform	BSE SME
Retail Allocation	Approx. 48.94% of the net issue
NII (HNI) Allocation	Approx. 48.94% of the net issue
QIB Allocation	Approx. 2.13% of the net issue

Important IPO Dates (Schedule Tracker)

Timing is everything in the stock market. Below is the tentative schedule for the IPO process. Make sure to mark these dates on your calendar if you plan to bid.

IPO Opens

May 20, 2026

IPO Closes

May 22, 2026

Allotment Status

May 25, 2026

Refunds / Demat Credit

May 26, 2026

Listing Date

May 27, 2026

Minimum Investment & Lot Size Breakdown

Unlike mainboard IPOs, SME IPOs have larger lot sizes and require a higher initial capital commitment. The minimum lot size for a retail investor is mapped out below.

Note: For Retail Investors, the minimum application size defined for this IPO is 2 Lots (2,400 shares), which amounts to a minimum investment of ₹2,30,400 at the upper price band.

Investor Category	Minimum Lots	Total Shares	Investment Amount (at ₹96)
Retail Individual Investor	2 Lots	2,400	₹2,30,400
Small HNI (S-HNI) Min	3 Lots	3,600	₹3,45,600
Small HNI (S-HNI) Max	8 Lots	9,600	₹9,21,600
Big HNI (B-HNI) Min	9 Lots	10,800	₹10,36,800

Why is Harikanta Overseas Raising Capital?

A fundamental check for any IPO is understanding how the company intends to utilize the raised funds. Harikanta Overseas has clearly outlined its capital allocation strategy, which focuses heavily on scaling its manufacturing capacity:

Machinery Purchase (₹9.33 Cr): A major chunk of the proceeds will be utilized to upgrade and expand their manufacturing machinery, enhancing production volume and efficiency.
Factory Premises (₹5.40 Cr): Funding capital expenditure for expanding their physical infrastructure.
Working Capital (₹4.75 Cr): To ensure smooth day-to-day operations and manage the supply chain efficiently.
General Corporate Purposes: Remaining funds will be deployed for broad operational initiatives.

Financial Health & Performance Metrics

Financial stability is the most critical metric for long-term investors. We have evaluated the restated consolidated financial numbers to give you a clear picture of the company’s trajectory.

Financial Metric	Period Ended Nov 30, 2025 (₹ in Cr)	Period Ended Mar 31, 2025 (₹ in Cr)
Total Assets	32.51	23.12
Total Revenue	26.28	35.50
EBITDA	7.35	6.72
Profit After Tax (PAT)	5.09	4.47
Net Worth	18.77	13.79
Total Borrowings	2.87	3.26

Key Performance Indicators (KPIs) & Valuation Insights

EBITDA Margin: Impressive growth observed, standing at 27.97% (as of Nov 2025).
PAT Margin: Healthy profitability with a 19.50% margin.
Return on Capital Employed (ROCE): A solid 31.99%, indicating efficient use of capital.
Debt-to-Equity Ratio: Maintained at a very low 0.15, signaling minimal leverage risk.
Valuation (P/E Ratio): The Pre-IPO P/E ratio is estimated at 15.46x, settling around 12.42x post-IPO.

Promoter Background & Shareholding Structure

The company is led by a capable management team comprising Hardik Gotawala, Abhishek Gotawala, and Nilesh Gotawala. The strength of promoter holding acts as a confidence booster for retail participants.

Shareholding Phase	Promoter Stake (%)
Pre-Issue Shareholding	96.87%
Post-Issue Shareholding	70.66%

Strategic SWOT Analysis

To provide a well-rounded perspective, here is an objective evaluation of the company’s internal and external market positioning.

Strengths

Diverse product range targeting high-demand segments (women’s ethnic wear). Established export footprint and strong presence in the domestic textile hub (Surat).

Weaknesses

Textile manufacturing is highly working-capital intensive. The business relies heavily on the steady supply of synthetic raw materials.

Opportunities

The proposed capital expenditure will expand machinery and scale up production, allowing the company to tap into broader global markets.

Threats

The SME textile segment is highly fragmented and competitive. Unpredictable shifts in fashion trends and fluctuating raw material costs pose constant risks.

Registrar and Lead Manager Details

For inquiries regarding allotment status, application forms, or refund processing, investors can reach out directly to the official registrar of the issue.

Registrar of the Issue: Bigshare Services Pvt. Ltd. (Email: ipo@bigshareonline.com)
Book Running Lead Manager: Interactive Financial Services Ltd.
Market Maker: Aftertrade Broking Pvt. Ltd.
Company Contact: info@harikantaoverseas.com

Final Thoughts

The Harikanta Overseas IPO presents an opportunity to invest in a growing entity within India’s robust textile sector. With a solid expansion plan mapped out through their capital expenditure objectives, low debt levels, and healthy EBITDA margins, the company appears positioned to scale its operations. However, the relatively high minimum investment threshold typical of SME IPOs requires investors to carefully weigh their risk appetite against the highly competitive nature of the garment industry.

As always, thorough research and portfolio alignment are key to successful investing. Keep a close watch on the subscription numbers starting May 20, 2026, to gauge broader market interest.

Thank you for reading this analysis on Publiclisting.in. Stay tuned for more deep dives into upcoming IPOs, market trends, and financial strategies!

May 16, 2026

Vegorama Punjabi Angithi

Vegorama Punjabi Angithi IPO: Complete Guide, Dates, Financials & Analysis | Publiclisting.in

Vegorama Punjabi Angithi IPO: Complete Guide, Dates, Financials & Comprehensive Analysis

Welcome back to Publiclisting.in! The Indian primary market continues to buzz with exciting opportunities, and the upcoming Vegorama Punjabi Angithi IPO is drawing significant attention from investors. Slated to hit the BSE SME board in May 2026, this quick-service restaurant (QSR) chain is looking to raise funds for its next phase of aggressive expansion.

If you are considering adding this SME IPO to your investment portfolio, it is crucial to understand the company’s business model, financial trajectory, valuation, and fundamental strengths. Let’s dive into an in-depth, data-backed review of the Vegorama Punjabi Angithi IPO.

Business Model: What Does Vegorama Punjabi Angithi Do?

Established in early 2022, Vegorama Punjabi Angithi Limited has rapidly carved a niche for itself in the vibrant food and beverage (F&B) sector. Operating under the popular brand name “Punjabi Angithi”, the company serves authentic, affordable, and high-quality vegetarian North Indian cuisine.

The company operates via a highly scalable, multi-format business model:

Cloud Kitchens: The backbone of their delivery network, operating 19 dedicated cloud kitchens across the Delhi NCR region (ranging from 400 to 870 sq. ft.).
Fine-Dining & QSR: Operating two premium fine-dining spaces (spanning around 2,400 sq. ft.) alongside quick-service dine-in setups.
Online Food Delivery: Seamless integration with top food aggregators like Zomato and Swiggy, supplemented by their own in-house delivery fleet.
Catering Services: Providing bulk food services for corporate events, parties, and private gatherings.

Core IPO Details

The company is launching a Book Built Issue to raise a total of ₹38.38 Crores. This includes a fresh issue of shares alongside a minor Offer For Sale (OFS) by the promoters. Below is a snapshot of the essential structural details of the offering:

Parameter	Details
IPO Open Date	May 20, 2026
IPO Close Date	May 22, 2026
Face Value	₹10 per share
Price Band	₹73 to ₹77 per share
Total Issue Size	49,84,000 shares (₹38.38 Cr)
Fresh Issue Size	37,36,000 shares (₹30.70 Cr)
Offer for Sale (OFS)	9,96,800 shares (₹7.68 Cr)
Listing Exchange	BSE SME

IPO Timeline & Critical Dates

Missing a deadline can mean missing out on a potential listing gain. Track the progress of the Vegorama Punjabi Angithi IPO using the timeline below:

Bidding Opens

May 20, 2026

Bidding Closes

May 22, 2026

Basis of Allotment

May 25, 2026

Refunds / Demat Credit

May 26, 2026

Listing on BSE SME

May 27, 2026

Investment Requirements: Lot Size Breakdown

For SME IPOs, retail investors cannot apply for single shares; they must apply in designated lot sizes. The price band upper limit of ₹77 dictates the minimum investment amount.

Investor Category	Minimum Lots	Total Shares	Investment Amount (at ₹77)
Retail (Min)	2 Lots	3,200	₹2,46,400
Retail (Max)	2 Lots	3,200	₹2,46,400
HNI / sNII (Min)	3 Lots	4,800	₹3,69,600
HNI / bNII (Min)	9 Lots	14,400	₹11,08,800

Quota Distribution (Net Issue)

QIB (Qualified Institutional Buyers): 49.97% (Includes Anchor Investor portion of 28.41%)
Retail Individual Investors: 35.02%
Non-Institutional Investors (HNI): 15.01%

Financial Health & Performance Metrics

A deep dive into the restated financial statements reveals significant growth in both top-line and bottom-line figures over the last three financial cycles. This upward trajectory is a strong indicator of brand acceptance and operational scaling.

Financial Metric (₹ in Crores)	31 Dec 2025 (9 Months)	31 Mar 2025 (FY25)	31 Mar 2024 (FY24)	31 Mar 2023 (FY23)
Total Assets	31.81	24.77	18.35	5.59
Total Revenue	105.35	102.06	66.37	16.91
Profit After Tax (PAT)	9.04	8.22	4.64	0.84
Net Worth	23.37	14.34	6.12	1.47
Total Borrowing	3.62	5.05	4.00	0.23

Key Performance Indicators (KPIs)

The operational efficiency of the company can be measured through its robust KPIs. The management has maintained strong margins while significantly reducing its debt-to-equity ratio ahead of the IPO.

Indicator	Value (As of latest filings)
EBITDA Margin	11.81%
PAT Margin	8.60%
Return on Equity (ROE)	47.93%
Return on Capital Employed (ROCE)	53.73%
Pre-Issue P/E Ratio	11.82x
Post-Issue P/E Ratio	10.61x
Price to Book Value (P/BV)	6.78

Strategic Objectives: How Will the Funds Be Used?

Transparency in capital allocation is key to building investor trust. Vegorama Punjabi Angithi intends to utilize the net proceeds of the fresh issue (approx. ₹23.32 Crores after issue expenses) for direct business scaling:

₹11.82 Crores: Allocated towards the construction of new banquets and fine-dining restaurants.
₹4.93 Crores: Dedicated to rolling out new cloud kitchens to deepen market penetration.
₹4.27 Crores: Setting up a state-of-the-art centralized kitchen to standardize taste, improve hygiene, and reduce per-unit production costs.
₹2.30 Crores: Upgrading and modernizing the existing cloud kitchen facilities.
Remaining Funds: Directed toward general corporate purposes.

Comprehensive SWOT Analysis

Before investing, it is vital to weigh the internal strengths against external market forces. Here is our exclusive SWOT analysis for Vegorama Punjabi Angithi Limited:

Strengths

Strong brand recall in the Delhi NCR region for affordable North Indian/Punjabi cuisine.
Asset-light cloud kitchen model minimizes rental overheads and boosts profit margins.
Stellar financial track record with revenue jumping from ₹16.91 Cr (FY23) to over ₹105 Cr (Dec FY25).

Weaknesses

Heavy geographical concentration; operations are currently heavily reliant on the Delhi NCR market.
High dependence on third-party aggregators (Zomato/Swiggy) which may squeeze margins through high commission rates.

Opportunities

Expansion into Tier-2 cities where the appetite for branded, hygienic QSR food is growing rapidly.
The proposed centralized kitchen will bring economies of scale, further boosting the EBITDA margin.
Growing trend of online food delivery post-pandemic acts as a continuous tailwind.

Threats

Intense competition from unorganized local eateries and established QSR chains.
Vulnerability to inflation in raw material costs (vegetables, dairy, cooking oils).
Changing consumer dietary trends moving towards health-conscious/vegan alternatives.

Promoter Holdings & Leadership

The company is led by a dedicated management team with deep roots in the F&B industry. The promoters steering the vision are Mr. Deepak Chadha, Mr. Subash Chander Chadha, and Mrs. Teenu Chadha.

Pre-Issue Promoter Holding: 99.41%
Post-Issue Holding: Will be diluted post-listing, ensuring sufficient public float and market liquidity.

Contact & Registrar Information

For allotment status, queries, or further official documentation, investors can reach out to the official registrar of the issue or the company directly.

Registrar to the Issue: Bigshare Services Pvt. Ltd.
Phone: +91-22-6263 8200
Email: ipo@bigshare.com

Company Address:
Vegorama Punjabi Angithi Ltd.
B-376, Third Floor, Meera Bagh, Outer Ring Road, Paschim Vihar, New Delhi – 110063
Phone: +91-11-46112637
Email: compliance@punjabiangithi.in

Lead Manager: Corporate Makers Capital Ltd.

Final Verdict & Key Takeaways

The Vegorama Punjabi Angithi IPO presents a compelling case for those looking to invest in the rapidly expanding Indian QSR and cloud kitchen segment. The company has demonstrated phenomenal top-line and bottom-line growth over a short span, successfully transitioning from a nascent startup to a highly profitable entity generating over ₹100 Crores in revenue.

The strategic deployment of funds toward a centralized kitchen and new geographic rollouts indicates a management focused on long-term scalability. While the SME space inherently carries a degree of volatility and risk, companies with strong fundamentals, clear cash flows, and a recognized consumer brand generally offer solid prospects.

As always, prospective investors should carefully evaluate their own risk appetite, review the overall market sentiment, and maintain a medium-to-long-term horizon when participating in SME IPOs.

Disclaimer: The information provided in this article is for educational and analytical purposes only. It does not constitute financial advice. Please consult with a certified financial advisor before making any investment decisions.

May 16, 2026

NFP Sampoorna Foods

NFP Sampoorna Foods IPO: Complete Analysis & Details – Publiclisting.in

In-Depth Analysis: NFP Sampoorna Foods SME IPO

As health-consciousness continues to shape consumer buying habits, the premium dry fruit and nuts sector is witnessing unprecedented growth. Stepping into the spotlight is NFP Sampoorna Foods, an established player in the processing and distribution of high-quality dry fruits, now preparing to launch its Initial Public Offering (IPO) on the NSE SME platform.

Whether you are a retail investor looking to diversify your portfolio or a High Net-Worth Individual (HNI) eyeing the FMCG space, understanding the fundamentals of an upcoming public issue is crucial. In this comprehensive guide, we break down the core business model, financial health, issue objectives, and valuation metrics of the upcoming NFP Sampoorna Foods IPO.

Overview of the Business: What Does NFP Sampoorna Foods Do?

Established in the year 2019, NFP Sampoorna Foods Ltd has swiftly carved a niche for itself in the premium health foods segment, primarily focusing on the processing and trading of dry fruits.

The company operates an end-to-end business model that begins with the global procurement of raw materials. A significant portion of their raw cashew is imported directly from Africa. By leveraging advanced roasting and packaging technologies, the brand ensures that the nutritional integrity and freshness of the nuts are meticulously preserved.

Core Product Portfolio:

Premium Cashew Nuts: Graded varieties including highly sought-after W320 and W400.
Almonds: Sourced from top-tier growers, available in both natural and roasted variants.
Makhana (Fox Nuts): Catering to the healthy snacking trend with plain, roasted, and flavored options.
Festive & Corporate Gifting: Curated gift hampers that see massive demand during the holiday and festival seasons.

Quality remains at the forefront of their operations. The company holds esteemed ISO 9001:2015 and ISO 22000:2018 certifications, validating their commitment to strict food safety and quality management. Their products reach consumers through a robust omnichannel distribution network, spanning traditional offline retail to massive e-commerce giants like Amazon, Flipkart, and their proprietary digital storefront.

NFP Sampoorna Foods IPO: Key Issue Details

The company is set to raise capital entirely through a fresh issue of shares, signaling intent to utilize funds directly for business scaling rather than providing an exit for existing promoters.

IPO Attribute	Details
Issue Type	Book Built Issue (Fresh Capital Only)
Total Issue Size	₹24.53 Crores (44,60,000 Equity Shares)
Face Value	₹10 per share
Price Band	₹52 to ₹55 per share
Market Lot Size	2,000 Shares
Listing Exchange	NSE SME
Pre-IPO Market Capitalization	₹69.49 Crores

IPO Schedule & Tracker

Timing is critical in the primary market. Below is the tentative timeline for the bidding, allotment, and listing phases of the issue.

May 18, 2026

Issue Opens

May 20, 2026

Issue Closes

May 21, 2026

Basis of Allotment

May 22, 2026

Refunds & Demat Credit

May 25, 2026

Listing Date

Investment Limits & Lot Sizes

The allocation is structured to accommodate Retail Individual Investors, Non-Institutional Investors (HNI), and Qualified Institutional Buyers (QIB). Below is the breakdown of minimum and maximum investment requirements.

Investor Category	Minimum Lots	Total Shares	Investment Amount (at ₹55)
Retail Investor (Min/Max)	1 Lot	2,000 Shares	₹1,10,000
Small HNI (Min)	2 Lots	4,000 Shares	₹2,20,000
Big HNI (Min)	10 Lots	20,000 Shares	₹1,10,000

Note: The net offer reserves approximately 49.58% for Retail Investors, 49.43% for HNIs, and 0.99% for QIBs. Market makers are allotted 2,24,000 shares.

Financial Performance Analysis

A transparent look at the historical financial data highlights the company’s trajectory in revenue generation, asset accumulation, and profitability.

Financial Metric (₹ in Crores)	FY 2023 (Mar 31)	FY 2024 (Mar 31)	FY 2025 (Mar 31)	FY 2026 (Nov 30)*
Total Assets	8.90	16.68	27.03	44.02
Total Revenue	16.75	6.00	35.76	36.96
Profit After Tax (PAT)	0.41	0.15	2.67	3.49
Net Worth	8.54	6.34	9.02	15.70
Total Borrowings	–	8.53	11.36	24.94

*Data up to November 30, 2025. The rapid jump in revenue and PAT in FY25 and the partial FY26 points to aggressive market expansion, though matched by a proportional increase in borrowings to fund this growth.

Key Valuation Metrics (KPIs)

Return on Equity (ROE): 28.21% (Robust return on shareholder funds)
Return on Capital Employed (ROCE): 24.71%
Debt to Equity Ratio: 1.59 (Indicates significant leverage)
PAT Margin: 9.46%
Pre-IPO P/E Ratio: 16.81x
Post-IPO P/E Ratio: 13.28x

Objectives of the Fresh Issue

Capital raised from the public markets will be strategically deployed to fortify the balance sheet and enhance operational liquidity.

Working Capital Requirements (₹7.25 Cr): To ensure a smooth supply chain, bulk procurement of raw cashews, and inventory management.
Debt Reduction (₹9.50 Cr): Prepayment or repayment of outstanding borrowings, which is expected to lower interest costs and improve bottom-line margins.
General Corporate Purposes: Utilizing the remaining balance for brand building, talent acquisition, and unforeseen operational needs.

SWOT Analysis of NFP Sampoorna Foods

Strengths

High-standard ISO certifications ensure product quality and consumer trust.
Diverse omnichannel presence across offline and online e-commerce platforms.
Experienced promoter group with deep industry relationships.

Weaknesses

Relatively high Debt-to-Equity ratio (1.59) restricting financial flexibility pre-IPO.
Heavy reliance on imported raw materials (Africa), exposing them to foreign exchange and logistical risks.

Opportunities

Surging domestic demand for healthy snacking and premium dry fruits.
Expanding B2B corporate gifting networks.
Potential to penetrate deeper into Tier-2 and Tier-3 cities in India.

Threats

Intense competition from both highly organized FMCG brands and unorganized local players.
Volatility in global raw material pricing and fluctuating agricultural yields.

Promoter Holding & Management

The company is steered by experienced promoters: Praveen Goel, Anju Goel, and Yash Vardhan Goel. Their extensive background in the agricultural commodity and FMCG sectors provides a solid foundation for the business.

Prior to the IPO, the promoters held a commanding 99.99% stake in the company. Following the issuance of new shares, this holding will be diluted, inviting public participation into the company’s growth story.

General Market Viewpoint

Market observers have noted the company’s consistent growth in top and bottom lines over recent financial periods, reflecting strong market demand for premium dry fruits. The issue appears to be fully priced based on recent earnings multipliers. Investors keeping an eye on this IPO should note recent structural changes, such as the induction of a new market maker and underwriter. Generally, such fully priced issues in highly competitive sectors are viewed as long-term wealth generation plays, making them suitable for cash-surplus investors willing to hold through market volatility.

Key Contacts & Intermediaries

Company Address	NFP Sampoorna Foods Ltd. Ground Floor B-3A & B-3B, Plot No 70, Najafgarh Road Industrial Area, Rama Road, New Delhi – 110015
Company Email	compliance@sampoornanuts.com
Lead Manager	3Dimension Capital Services Ltd.
Registrar to the Issue	Skyline Financial Services Pvt. Ltd.
Market Maker	Anant Securities

Conclusion

The NFP Sampoorna Foods IPO presents an interesting opportunity to invest in India’s booming health foods and dry fruit sector. With solid revenue growth, a clear roadmap to reduce debt via the IPO proceeds, and an established distribution network, the fundamentals look promising. However, prospective investors must weigh these strengths against the inherent risks of a debt-heavy pre-IPO balance sheet and intense sector competition. As always, assessing personal risk appetite and conducting thorough due diligence is advised before subscribing to any SME issue.

May 16, 2026

Teamtech Formwork Solutions

Teamtech Formwork Solutions IPO: In-Depth Analysis, Dates, and Financials

Publiclisting.in

Teamtech Formwork Solutions IPO: Complete Analysis, Subscription Details, and Financial Outlook

The Indian infrastructure sector is undergoing massive expansion, and with it comes a surging demand for modern construction methodologies. Enter Teamtech Formwork Solutions Ltd., a company preparing to tap into the primary markets through its upcoming SME Initial Public Offering (IPO). This comprehensive guide provides you with essential insights into the company’s business model, valuation metrics, critical timeline dates, and overall investment prospects.

Business Overview: What Does Teamtech Formwork Solutions Do?

Established in November 2018, Teamtech Formwork Solutions Limited operates on a dedicated Business-to-Business (B2B) framework. The company specializes in manufacturing, refurbishing, and renting out modular T-formwork systems that are essential for the modern construction industry.

Product Portfolio: They offer a comprehensive range of standard panels, customized formwork systems, and specialized supporting accessories tailored to various structural needs.
Application Areas: Their engineering solutions are heavily utilized for vertical concrete structures, including shafts, foundations, bridges, commercial walls, circular tanks, and complex foundations.
Infrastructure Hub: The company boasts an expansive 20,000 sq. ft. in-house manufacturing and refurbishment facility located in Bollaram, Telangana. This facility integrates advanced laser and plywood cutting machinery alongside top-tier planning software for project estimation.

Core Details of the Public Issue

The company is aiming to raise fresh capital from the market through a fully book-built issue. Below are the structural parameters of the offering:

Particulars	Details
IPO Open Date	May 19, 2026
IPO Close Date	May 21, 2026
Issue Size	₹50.15 Crores (7,960,000 shares)
Issue Type	100% Fresh Issue (Book Built)
Face Value	₹5 per share
Price Band	₹61 to ₹63 per share
Listing Exchange	NSE SME

Critical Dates & IPO Timetable

Staying ahead of crucial deadlines is vital for a smooth application process. The visual timeline below tracks the journey from the issue opening to its grand debut on the stock exchange.

✓

IPO Opens

May 19, 2026

IPO Closes

May 21, 2026

Allotment Status

May 22, 2026

Refunds & Credit

May 25, 2026

Listing Date

May 26, 2026

Investment Lot Size & Subscription Categories

The offering is neatly categorized to accommodate various investor classes, including Retail Individual Investors, High Net Worth Individuals (HNIs), and Qualified Institutional Buyers (QIBs).

Important Application Note: While the base lot size is mathematically 2,000 shares, the official mandate requires retail investors to place a minimum bid of 4,000 shares (2 lots).

Investor Category	Minimum Lots	Total Shares	Investment Amount (at Upper Band)
Retail Investor (Min & Max)	2 Lots	4,000 Shares	₹2,52,000
Small HNI (Min)	3 Lots	6,000 Shares	₹3,78,000
Small HNI (Max)	7 Lots	14,000 Shares	₹8,82,000
Big HNI (Min)	8 Lots	16,000 Shares	₹10,08,000

Reservation Quota: The net offer restricts reservations to specific limits—QIBs command 49.97% (including anchor portions), Retail takes 35.03%, and Non-Institutional Investors (NII/HNI) are allocated 15.00%. A 5.03% segment is carved out for the Market Maker to ensure post-listing liquidity.

Financial Health & Valuation Metrics

A deep dive into the financial statements reveals an aggressive growth trajectory, particularly in the most recent fiscal year.

Financial Parameter (₹ in Crores)	FY 2024	FY 2025	FY 2026
Total Assets	24.96	40.00	66.75
Total Income	30.31	32.98	54.23
Profit After Tax (PAT)	7.69	7.84	11.59
Net Worth	13.79	21.63	33.22
Total Borrowing	3.64	11.10	16.68

Key Performance Indicators (KPIs)

As of March 31, 2026, the company showcases highly competitive valuation metrics:

Return on Equity (ROE): 42.26%
Return on Capital Employed (ROCE): 40.92%
Debt-to-Equity Ratio: 0.50
PAT Margin: 21.60%
EBITDA Margin: 32.61%

Promoters & Objective of the Issue

The company is spearheaded by visionary promoters: Eldo Varghese, Chaitanya Prakash Kotagiri, and Salinraj Kunnummal. Prior to the IPO, the promoters held a commanding 81.25% stake in the entity.

The net proceeds generated from the ₹50.15 crore fresh issue will be mobilized for the following strategic objectives:

Capital Expenditure: ₹11.92 Crores allocated for purchasing new plant machinery for an upcoming manufacturing unit.
Debt Reduction: ₹15.50 Crores earmarked for the repayment or prepayment of existing borrowings, which will improve the balance sheet.
Working Capital: ₹13.77 Crores to fuel day-to-day operational requirements.
General Corporate Purposes: The balance amount will be utilized for broader business development initiatives.

SWOT Analysis of Teamtech Formwork Solutions

Strengths

The company benefits from a robust B2B model backed by long-standing client relationships. An impressive Return on Equity (over 42%) and an integrated in-house manufacturing process create a solid competitive moat.

Weaknesses

General market sentiment observes that the massive spike in revenue and net profit specifically in FY26 raises legitimate questions regarding the long-term sustainability of such high margins. The valuation appears to price in perfect future execution.

Opportunities

With India experiencing a rapid infrastructure and real estate boom, the demand for scalable, customized, and modular construction equipment like T-formworks is poised to surge tremendously.

Threats

The construction ancillary market is highly fragmented. Intensive competition from unorganized sectors, potential raw material pricing volatility, and macroeconomic shifts in the real estate sector remain ongoing threats.

Key Contact & Intermediary Information

For application-related queries or company communication, investors can refer to the following official channels:

Registrar to the Issue: Kfin Technologies Ltd. (Contact: 040-67162222 / teamtech.ipo@kfintech.com)
Lead Manager: GetFive Advisors Pvt. Ltd.
Market Maker: SMC Global Securities Ltd.
Company Registered Office: 3rd Floor, Plot No. 1050/1, Sree Sai Enclave, Hydernagar, Hyderabad, Telangana – 500049.

Final Thoughts

The Teamtech Formwork Solutions IPO brings forward an intriguing blend of stellar margin profiles and aggressive recent growth. Its firm footing in an infrastructure-hungry economy provides a compelling narrative. However, the premium valuation demands that investors weigh the remarkable FY26 performance against future sustainability metrics. Balancing the strong market dynamics with the inherent risks of SME investing is vital before making capital commitments.

May 16, 2026

Goldline Pharmaceutical

Goldline Pharmaceutical IPO: Complete Analysis, Dates, and Financial Review

The Indian pharmaceutical sector continues to be a robust engine for economic growth, and emerging companies are rapidly capitalizing on this momentum. One such enterprise stepping into the public markets is Goldline Pharmaceutical Ltd. Operating on an efficient, asset-light business model, the company is launching its SME Initial Public Offering (IPO) on the BSE SME platform.

Whether you are a seasoned investor or a market enthusiast looking for fresh opportunities, understanding the core fundamentals, financial trajectory, and strategic goals of a company is vital. Below is a comprehensive, data-backed breakdown of the Goldline Pharmaceutical IPO to help you make an informed decision.

Business Overview: What Does Goldline Pharmaceutical Do?

Unlike traditional pharmaceutical giants that maintain heavy manufacturing infrastructure, Goldline Pharmaceutical Ltd. operates primarily as a specialized marketing and distribution powerhouse. Marketed under their proprietary brand name “Goldline,” the company’s product portfolio is meticulously segmented to target specific medical specialties.

Their operational strategy relies on partnering with high-quality, third-party manufacturers. By conducting deep market research and defining precise product specifications, Goldline ensures regulatory compliance without the overhead costs of manufacturing plants.

The company operates across five distinct product divisions:

Goldline Pharma (42 Products): Focused on general specialties including Orthopedics, Gastroenterology, Neurology, and Urology.
Goldline Cardinal (54 Products): Tailored for super-specialists such as Cardiologists, Endocrinologists, and Diabetologists.
Goldline Aayushman (18 Products): Dedicated to pediatric care, child specialists, and neonatologists.
Goldline InLife (22 Products): Critical care products designed for intensivists and super-specialty surgeons.
Goldline Wellness (10 Products): Supportive care ranges, playing a critical role in therapies like oncology and general recovery.

Currently, the company collaborates with 15 third-party manufacturers and utilizes a network of 7 primary distributors to reach retailers and hospitals across states like Maharashtra, Madhya Pradesh, Odisha, Jharkhand, Tamil Nadu, Rajasthan, and Bihar.

Goldline Pharmaceutical IPO Event Timeline

Tracking the critical dates is the first step in successful IPO participation. Below is the scheduled timeline from the opening of the subscription window to the market debut.

Issue Opens

Tue, May 12, 2026

Issue Closes

Thu, May 14, 2026

Basis of Allotment

Fri, May 15, 2026

Refunds & Demat Credit

Mon, May 18, 2026

Market Listing

Tue, May 19, 2026

Core Initial Public Offering Specifications

The company aims to raise a total of ₹11.61 Crores (approx. ₹12 Cr) entirely through a fresh issue of shares. Here are the granular details of the offering:

Parameter	Detail
Issue Type	Book Built Issue (SME)
Face Value	₹10 per equity share
Price Band	₹41 to ₹43 per share
Total Issue Size	27,00,000 shares (Aggregating to approx. ₹11.61 Cr)
Fresh Issue	27,00,000 shares
Listing Platform	BSE SME
Market Maker Quota	1,38,000 shares

Investment Quotas and Lot Constraints

Participation in SME IPOs requires bidding in specific lot multiples. For retail investors, the entry barrier is set higher compared to mainboard IPOs to ensure informed investing. Institutional and Non-Institutional quotas are appropriately segmented to maintain fair distribution.

Investor Category	Minimum Lots	Total Shares	Minimum Investment Limit
Retail Individual Investors	2 Lots	6,000 shares	₹2,58,000
Small HNI (S-HNI)	3 Lots	9,000 shares	₹3,87,000
Big HNI (B-HNI)	8 Lots	24,000 shares	₹10,32,000

Note: Qualified Institutional Buyers (QIB) are allocated up to 50% of the net issue, while Non-Institutional Investors (NII) get up to 15%. Retail investors are reserved a solid 35% portion of the net offering.

Historical Financial Health

A company’s historical financial data is the most reliable indicator of its growth trajectory. Over the past three fiscal years, Goldline Pharmaceutical has demonstrated a consistent upward trend in both revenue generation and profitability.

Financial Metric (in ₹ Crores)	FY Ending Mar 31, 2023	FY Ending Mar 31, 2024	FY Ending Mar 31, 2025
Total Assets	19.39	22.93	26.28
Total Revenue	19.85	23.57	28.06
Profit After Tax (PAT)	0.26	1.81	2.83
EBITDA	2.19	4.30	5.83
Net Worth	5.89	7.87	10.35
Total Borrowing	10.83	11.13	11.03

Observation: Between FY2024 and FY2025, the company registered a healthy 19% increase in top-line revenue, accompanied by an impressive 57% surge in Profit After Tax (PAT), indicating improved operational efficiencies.

Company Valuation Metrics

Pricing an IPO accurately is crucial for listing gains and long-term holding. Based on the upper price band of ₹43, here are the key performance indicators (KPIs) and valuation metrics:

Valuation Indicator	Data (As of March 2025)
Pre-IPO EPS (Earnings Per Share)	₹4.11
Post-IPO EPS	₹2.95
Pre-IPO P/E Ratio	10.47x
Post-IPO P/E Ratio	14.56x
Return on Equity (ROE)	35.84%
Return on Capital Employed (ROCE)	38.46%
Pre-IPO Market Capitalization	₹41.28 Crores

Primary Objectives of the Public Issue

Transparency regarding how raised capital will be deployed builds trust. The company has outlined precise objectives for utilizing the estimated net proceeds:

Debt Reduction: A significant portion of the funds, approximately ₹8.90 Crores, is earmarked for the prepayment or scheduled repayment of outstanding corporate borrowings. This move is strategically intended to lower interest burdens and improve future profit margins.
General Corporate Purposes: The residual capital will be deployed to fund everyday operational needs, strategic growth initiatives, and other corporate requirements.

Strategic SWOT Analysis

To provide a holistic view of the company’s market positioning, here is an objective SWOT breakdown:

Strengths

Highly scalable, asset-light business model requiring low capital expenditure.
Diverse product range serving multiple medical super-specialties.
High Return on Capital Employed (38.46%).

Weaknesses

Complete reliance on third-party manufacturers limits direct control over production.
Elevated Debt-to-Equity ratio (1.50) prior to the IPO capital injection.

Opportunities

Geographic expansion into highly populated, under-penetrated Indian states.
Rising healthcare expenditure and demand for branded generics across India.
Proceeds from IPO will significantly de-leverage the balance sheet.

Threats

Intense competition from both established pharma giants and localized generic brands.
Strict and evolving government regulations regarding pharmaceutical pricing and distribution.

Leadership, Ownership, & Registrar Details

Corporate Promoters: The company’s vision is driven by Amol Laxmikant Mujumdar and Swapan Premprakash Khandelwal. Currently, the promoters hold a strong 79.70% stake in the business, reflecting high skin-in-the-game prior to the IPO dilution.

Official Lead Manager: Cumulative Capital Pvt. Ltd. has been appointed to steer the book-building process and manage the listing procedures.

Registrar Information	Corporate Contact Details
Bigshare Services Pvt. Ltd. Phone: +91-22-6263 8200 Email: ipo@bigshareonline.com	Goldline Pharmaceutical Ltd. 103, F-1, Leela Apartment, Shilpa HSG Society, Narendra Nagar, Nagpur, Maharashtra, 440015 Phone: +91 712 2786666 Email: info@goldlinepharma.in

Summary & Key Takeaways

The Goldline Pharmaceutical IPO presents an interesting proposition for investors eyeing the SME healthcare space. The company’s asset-light framework allows for rapid scalability without the capital drains associated with heavy manufacturing. With impressive historical revenue growth, strong PAT margins, and a clear objective to reduce existing corporate debt, the fundamental setup looks promising.

However, prospective investors should weigh the high initial retail investment barrier (₹2,58,000) and the inherent risks of relying entirely on third-party manufacturing logistics. As with any equity investment, aligning this SME IPO with your personal risk appetite and long-term portfolio strategy is highly recommended.

May 7, 2026

RFBL Flexi Pack

Comprehensive Guide to RFBL Flexi Pack IPO: Dates, Price, Financials & Analysis

Comprehensive Guide to RFBL Flexi Pack IPO: Dates, Price Band, Financials & In-Depth Analysis

Welcome to another detailed analysis on Publiclisting.in! The SME market is buzzing with fresh opportunities, and the upcoming RFBL Flexi Pack IPO is capturing significant attention from the investment community. If you are looking to diversify your portfolio with emerging small and medium enterprises, understanding the fundamental and technical aspects of this public issue is highly crucial.

In this comprehensive guide, we will break down exactly what RFBL Flexi Pack Ltd. does, delve into their financial health, scrutinize the IPO valuation, outline important dates, and conduct a SWOT analysis to help you make an informed decision.

Company Overview: What Does RFBL Flexi Pack Ltd. Do?

Incorporated in July 2005, RFBL Flexi Pack Ltd. has built a steady footprint in the packaging industry. The company is primarily engaged in the manufacturing and trading of printed multilayer flexible packaging materials.

Product Portfolio: The company specializes in creating customized plastic film rolls and pouches. They also trade in Woven Fabric Packaging Material, Polyester Laminated films, and various other flexible packaging films.
Industry Focus: Their advanced packaging solutions serve multiple high-demand sectors, including the food and beverage industry, pharmaceuticals, and home care segments.
Business Model: Operating strictly on a B2B (Business-to-Business) framework, they cater to corporate clients requiring bulk, high-quality, and highly reliable customized packaging solutions.
Operational Infrastructure: Their primary manufacturing unit is strategically located in Himatnagar, Gujarat, a region well-known for its industrial output.

Key IPO Details at a Glance

The RFBL Flexi Pack IPO is entirely a fresh issue of shares, aimed at raising capital to scale up current operations. Below is the structural overview of the initial public offering.

Parameter	Details
Issue Type	Book Built Issue (SME)
Total Issue Size	₹35.33 Crores (70,65,000 Equity Shares)
Face Value	₹10 per share
Price Band	₹47 to ₹50 per share
Listing Exchange	NSE SME
Market Maker Allocation	67,11,000 shares
Net Offer to Public	3,54,000 shares

IPO Schedule & Timeline Tracker

Mark your calendars! Keeping track of the exact timeline ensures you don’t miss out on the application window, allotment status, or listing day.

Issue Opens

May 12, 2026

Issue Closes

May 14, 2026

Basis of Allotment

May 15, 2026

Refunds & Credit

May 18, 2026

Listing Date

May 19, 2026

Investment Limits: Lot Size Requirements

SME IPOs require a slightly higher capital commitment compared to mainline IPOs. Based on the price band, investors must apply in specific multiples (lots).

Investor Category	Minimum Lots	Total Shares	Minimum Investment Amount
Retail Individual Investor	2 Lots	6,000 Shares	₹3,00,000
Small HNI (S-HNI)	3 Lots	9,000 Shares	₹4,50,000
Big HNI (B-HNI)	7 Lots	21,000 Shares	₹10,50,000

Financial Health & Track Record

A deep dive into the financial restatements gives us a clear picture of how rapidly RFBL Flexi Pack is growing and managing its balance sheet. (Figures are in ₹ Crores)

Particulars	Sept 30, 2025 (H1)	Mar 31, 2025 (FY25)	Mar 31, 2024 (FY24)	Mar 31, 2023 (FY23)
Total Assets	51.54	46.94	22.48	10.21
Total Income	69.66	135.46	79.96	46.86
EBITDA	5.96	12.57	8.53	1.34
Profit After Tax (PAT)	3.84	8.33	5.79	0.67
Net Worth	21.84	18.00	9.68	3.89
Total Borrowings	17.51	18.88	5.23	2.06

Financial Insight: The company has demonstrated a massive jump in Total Income from ₹46.86 Cr in FY23 to ₹135.46 Cr in FY25. Correspondingly, profits surged from ₹0.67 Cr to ₹8.33 Cr during the same timeframe. However, investors should also note the increase in total borrowings to fuel this rapid scale-up.

Valuation Metrics & Key Performance Indicators (KPIs)

Valuation determines whether the stock is offered at a premium, fair, or discounted price compared to its internal growth.

Metric	Value (Based on FY25 / Pre-IPO Data)
Return on Equity (ROE)	60.18%
Return on Capital Employed (ROCE)	32.70%
Debt to Equity Ratio	1.05
Price to Book Value (P/B)	4.51
Pre-IPO P/E Ratio	9.75x
Post-IPO P/E Ratio	15.19x
Pre-Issue Market Cap	₹116.58 Crores

Primary Objectives of the Public Offer

Understanding where the capital raised will be deployed is vital for predicting future scalability. RFBL Flexi Pack aims to utilize the net proceeds of ₹30.18 Cr for:

Capital Expenditure: ₹12.41 Crores allocated for upgrading machinery and expanding infrastructure.
Working Capital Requirements: ₹17.76 Crores to manage day-to-day operations seamlessly and fill cash flow gaps caused by business expansion.
General Corporate Purposes: Utilizing the remaining balance for standard corporate necessities.

Promoter Holding & Management

The company is propelled by promoters Kunjit Maheshbhai Patel and Roopyaa Tradebizz Limited. Tracking the promoter holding before and after the public issue indicates the level of “skin in the game” the founders retain.

Pre-Issue Promoter Holding: 100.00%
Post-Issue Promoter Holding: 69.70%

SWOT Analysis of RFBL Flexi Pack Ltd.

A strategic overview of the internal and external factors influencing the company’s future growth.

Strengths

Integrated Operations: A self-reliant manufacturing operation ensures tighter quality control and timely delivery.
Customized Flexibility: Ability to offer flexible packaging tailored to niche requirements of pharmaceutical and FMCG clients.
Strong Financial Rebound: Excellent PAT and Revenue growth demonstrated over the past three fiscal years.

Weaknesses

Rising Debt Levels: The debt-to-equity ratio has increased, making them slightly vulnerable to interest rate fluctuations.
Supplier Dependency: Heavy reliance on the price of raw plastics and polymers, which are generally volatile.

Opportunities

Sector Expansion: The Indian e-commerce, food delivery, and pharmaceutical sectors are booming, leading to massive demands for multi-layer packaging.
Geographical Expansion: Funds from the IPO can be utilized to expand footprints outside the home state of Gujarat.

Threats

Intense Competition: The packaging industry is highly fragmented with numerous unorganized and organized players.
Environmental Regulations: Shifting government policies regarding plastic usage could force the company into expensive eco-friendly transitions.

Contact & Intermediary Details

For further verification and inquiries, investors can reach out to the official registrars and the company management directly.

Registered Office	Survey No 32, Plot No 15, Behind Marutinandan Temple, Dhandha, Sabarkantha, Himatnagar, Gujarat, 383001
Company Email	info@rfblflexipack.com
Lead Manager	Grow House Wealth Management Pvt. Ltd.
Registrar to the Issue	Kfin Technologies Ltd. (Email: rfbl.ipo@kfintech.com)

Conclusion: Should You Apply?

The RFBL Flexi Pack IPO presents a robust opportunity given the company’s excellent financial growth trajectory and an impressive Return on Equity (ROE) of over 60%. The capital raised is clearly marked for working capital and infrastructure expansion, highlighting the management’s focus on future scaling.

However, the SME nature of the IPO means lot sizes and investment capital are comparatively large, and the increasing debt levels warrant a careful look. As the packaging sector continues to thrive alongside the FMCG and Pharma boom, RFBL is strategically positioned to capture significant market share. Standard market sentiment suggests reviewing your personal risk appetite and consulting with a certified financial advisor before placing your bids.

May 7, 2026

Simca Advertising
Simca Advertising SME IPO: A Strategic Analysis for Investors
Detailed insights into the upcoming NSE SME public offer from Publiclisting.in
The Out-of-Home (OOH) advertising sector is witnessing a digital transformation, and Simca Advertising Limited is stepping into the spotlight with its upcoming Initial Public Offering (IPO). This guide provides a comprehensive breakdown of the issue to help you make informed investment decisions.
Company Overview: What Does Simca Advertising Do?
Incorporated in 2022, Simca Advertising has rapidly established its footprint in the OOH media landscape, primarily focusing on Mumbai and the wider Maharashtra region. The company utilizes a diverse array of advertising assets, including:
High-traffic hoardings and gantries
Bus panels and strategic shelter signage
Digital OOH (DOOH) displays and kiosks
Utility-based advertising structures
With an ISO 9001:2015 certification, the company serves a broad spectrum of clients ranging from real estate giants and fashion brands to various government organizations.
IPO Schedule: Important Dates
Event Date
Subscription Opens May 8, 2026
Subscription Closes May 12, 2026
Allotment Finalization May 13, 2026
Listing Date May 15, 2026
Progress: IPO Phase (60% Complete)
Financial Health & Investment Metrics
Metric Details
Issue Size ₹58.04 Crores
Price Band ₹174 – ₹183 per share
Lot Size 600 Shares
Min. Retail Investment ₹2,19,600
SWOT Analysis: Examining the Business
Strengths
Strong presence in high-traffic Mumbai zones.
Scalable digital advertising model.
Experienced management team.
Weaknesses
Operating in a highly fragmented and competitive industry.
Capital-intensive requirements for digital screen installations.
Objectives of the Issue
The company intends to channel the net proceeds from the IPO into the following key areas:
Infrastructure Expansion: Purchase and installation of new LED screens.
Strategic Partnerships: Collaborations for monetization of digital advertising assets.
Working Capital: Strengthening operational cash flow.
General Corporate Purposes: Managing routine business overheads.
Key Takeaways for Investors
Simca Advertising has shown consistent growth in its top and bottom-line figures over the last few fiscal periods. While the financial metrics appear robust, the SME market inherently carries higher risks compared to mainboard listings. Investors should conduct thorough due diligence, review the Red Herring Prospectus (RHP), and consider their risk appetite before committing funds.
Disclaimer: This content is for informational purposes only and does not constitute financial advice. Please consult with a certified investment advisor before making any stock market investments.
© 2026 Publiclisting.in – All Rights Reserved.
May 7, 2026